The filing reveals a director's ongoing monetization via a 10b5-1 plan, with three prior sales in 2026 totaling ~$14.3M. While the plan was pre-arranged, the consistent selling pattern by a director may signal a lack of conviction in near-term upside. Monitor for any acceleration of sales or additional insider filings.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 14 $29.00entry
- T+1 · 5w ago +3.31%α +3.03% · $29.96
- T+5 · 27d ago +4.72%α +4.27% · $30.37
- T+20 · 6d ago +14.07%α +15.34% · $33.08
- T+24 · todayOpen
- T+60 · in 8w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Ryan A. King (King Family Trust) filed a Form 144 notice to sell 75,000 shares of Chime Financial common stock, with an estimated aggregate market value of $2,283,750. The sale is planned for execution on or about October 13, 2026, and is part of a pre-arranged 10b5-1 trading plan. The filing also discloses three prior 10b5-1 sales in 2026 totaling approximately 467,421 shares for about $14.3 million, indicating a pattern of consistent insider monetization.
Key Facts
- Director Ryan A. King (King Family Trust) intends to sell 75,000 shares of Chime Financial common stock.
- Estimated aggregate market value of the proposed sale is $2,283,750.
- The sale is scheduled for October 13, 2026, and is executed under a 10b5-1 trading plan.
- Prior 10b5-1 sales in 2026: 50,000 shares on 10/09/2026 ($1.47M), 42,421 shares on 09/09/2026 ($1.49M), and 375,000 shares on 08/06/2026 ($11.35M).
- Total disclosed 10b5-1 sales in 2026: approximately 467,421 shares for about $14.3 million.
- The shares to be sold were acquired on 10/10/2019 via previously exercised stock options.
Financial Impact
Proposed sale of 75,000 shares valued at $2.28 million; cumulative 10b5-1 sales in 2026 total ~$14.3 million.
Risk Factors
- Insider selling may pressure the stock if the market interprets it as a lack of confidence.
- The 10b5-1 plan provides a legal shield, but the cumulative volume (~467K shares) is material relative to typical trading volumes.
- No offsetting insider buying has been disclosed to counterbalance the selling pattern.
Investment Themes
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010203 |
| Document: 0001950047-26-010203.txt | 0001950047-26-010203 |
Track record
39 reports on CHYM
9 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +14.85% at T+5 after the Sep 14, 2026 report. 12 of 13 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 17, 2026today 144 Neutral 3/10 Entry $32.98 Now $32.97 −0.03% settles Nov 25
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 3/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 13, 20264d ago SC 13G/A Neutral 3/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers